Purpose: To functionally evaluate an apodized diffractive multifocal intraocular lens (IOL) using an electronic reading desk (Salzburg Reading Desk).
Setting: University Eye Clinic Heidelberg, Heidelberg, Germany.
Design: Prospective case series.
Methods: After implantation of an Acrysof IQ Restor +3.0 diopter (D) multifocal IOL, uncorrected (UDVA) and corrected (CDVA) distance visual acuities, uncorrected (UNVA) and distance-corrected (DCNVA) near visual acuities, and uncorrected (UIVA) and distance-corrected (DCIVA) intermediate visual acuities were determined. Criteria for evaluating reading acuity were the reading speed and print size. Monocular and binocular examinations were performed with the electronic reading desk at fixed distances and at the patient's preferred near and intermediate distances. In addition, a subjective questionnaire was administered.
Results: Forty eyes (20 patients) were enrolled. Monocularly, the medians were UDVA, 0.00 logMAR (range 0.26 to -0.14 logMAR); CDVA, -0.08 logMAR (range 0.16 to -0.24 logMAR); 40 cm UNVA, 0.04 logMAR (range 0.24 to -0.10 logMAR); DCNVA, 0.00 logMAR (range 0.18 to -0.22 logMAR); 80 cm UIVA, 0.15 logMAR (range 0.40 to -0.18 logMAR); DCIVA, 0.16 logMAR (range 0.42 to -0.14 logMAR). The monocular reading desk examinations resulted in an uncorrected reading acuity of 0.11 logMAR (range 0.49 to -0.01 logMAR) at 40 cm and 0.30 logMAR (range 0.48 to 0.00 logMAR) at 80 cm. Patients reported a high rate of spectacle independence and satisfaction in everyday life.
Conclusion: The +3.0 D IOL provided good postoperative functional results at far and near and improved the visual and reading acuity at an intermediate distance.
Financial Disclosures: The International Vision Correction Research Centre has received research grants, travel expenses, and lecture fees from various intraocular lens manufacturers. None of the authors has a financial or proprietary interest in any material or method mentioned.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcrs.2015.11.047 | DOI Listing |
Retina
January 2025
Department of Ophthalmology, University Medical Center Rostock, Rostock, Germany.
Purpose: Formation of a full thickness macular hole (FTMH) after vitrectomy is rare. The aim of this study was to describe risk factors, clinical course, anatomical and functional prognosis of secondary FTMH development following surgery for primary rhegmatogenous retinal detachment (RRD).
Methods: Retrospective study.
Eye (Lond)
January 2025
Retinoblastoma Service, Royal London Hospital, London, UK.
Purpose: To evaluate the efficacy of ultrasound-guided ruthenium (Ru 106) plaque brachytherapy for treatment of exudative retinal detachment in diffuse choroidal haemangioma (DCH).
Methods: Retrospective analysis of four paediatric patients treated with ultrasound-guided Ru 106 plaque brachytherapy for DCH with total exudative retinal detachment directed to the thickest part of the DCH. A dose of 40 Gy to the tumour apex was delivered in all patients.
Heliyon
January 2025
Faculty of Medical and Health Sciences, Tel Aviv University, Israel.
Objective: Pigmentary posterior vitreous detachment (PVD), referred to as "black PVD," is a rare entity describing PVD along with pigment dispersion in the vitreous. There are a few case reports describing pigmentary PVD, yet the association between pigmentary PVD and uveal and optic disc tumors was not described before. The aim of this study was to report the clinical features of patients with pigmentary PVD associated with these tumors.
View Article and Find Full Text PDFCan J Ophthalmol
January 2025
Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. Electronic address:
Objective: Biallelic RPE65 pathogenic variants may cause Leber congenital amaurosis (LCA). Voretigene neparvovec-rzyl (VN, Luxturna) is the only approved subretinal gene therapy that demonstrated benefit and safety. The eligibility criteria are vague and variable between centres.
View Article and Find Full Text PDFClin Ophthalmol
December 2024
The Department of Ophthalmology, The Shammas Eye Medical Center, Lynwood, CA, USA.
Purpose: To evaluate the clinical outcomes of a new FDA approved toric aspheric hydrophobic acrylic intraocular lens.
Patients And Methods: This is a single surgeon, single-arm, on-label, non-randomized, prospective observational study. Thirty patients underwent bilateral cataract surgery (60 eyes) with placement of a Clareon™ Toric IOL in each eye.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!